Center for Vaccine Research

Federal funding is an important part of supporting research and innovation in universities. Pitt’s Evan Facher describes how the novel coronavirus could change the equation.

The Coalition for Epidemic Preparedness Innovations is committing nearly $5 million to a consortium that includes the University of Pittsburgh’s Center for Vaccine Research to develop a vaccine for the novel coronavirus.

More than 250 people attended a panel discussion on Feb. 12 to hear a group of Pitt and county experts discuss the coronavirus outbreak.

The University of Pittsburgh is among a select few institutions expected to receive samples of the coronavirus for study. In his remarks to the University Senate, Paul Duprex, director of the Center for Vaccine Research, highlighted the tremendous history the University has in working on vaccines and why this matters.

As part of the global push to prevent tuberculosis, Distinguished Professor JoAnne Flynn and a group of Pitt and National Institutes of Health researchers have discovered that intravenously injecting the standard tuberculosis vaccine could boost its power.